Showing 1871-1880 of 3329 results for "".
- Crown Aesthetics Expands Further Into the APAC Regionhttps://modernaesthetics.com/news/crown-aesthetics-expands-further-into-the-apac-region/2473424/Crown Aesthetics is expanding further into the Asia Pacific ("APAC") Region, and Jeff Sinclair will lead the charge as the new Executive Director of Sales, Asia. "Our expansion into the Asian market is significant," says Michael Mc
- FDA Approves Galderma's Restylane Eyelighthttps://modernaesthetics.com/news/fda-approves-galdermas-restylane-eyelight/2473423/The U.S. Food and Drug Administration (FDA) approved Restylane Eyelight, a hyaluronic acid (HA) dermal filler for the correction of undereye hollowing, in adults over the age of 21. Restylane Eyelight is formulated with NASHA Technology, which has a firm gel te
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- Study Shows Preventive Effects and Protective Potential of Astaxanthin on Collagen Damagehttps://modernaesthetics.com/news/study-shows-preventive-effects-and-protective-potential-of-astaxanthin-on-collagen-damage/2473411/A study recently found that Lycored's astaxanthin prevented against collagen damage from neutrophils, discovering its potential to protect collagen and enhance skin health. The study,
- Updated: Cutera CEO, Executive Chairman Axedhttps://modernaesthetics.com/news/cutera-ceo-top-investor-call-for-removal-of-board-members/2473390/Cutera Inc has fired CEO David Mowry and Executive Chairman Daniel Plants for alleged violations of their employment contracts. Sheila Hopkins has been appointed as interim CEO and the search for a permanent replacement is underway. Plants and Mowry called for a Spec
- Binge Watch Alert: The Aesthetic Society Drops New Episodes of Beyond the Before & Afterhttps://modernaesthetics.com/news/binge-watch-alert-the-aesthetic-society-drops-new-episodes-ofbeyond-the-before-after/2473389/The Aesthetic Society dropped four new episodes of their original docuseries 'Beyond the
- CoolSculpting Elite Announces First-Ever CoolMonthhttps://modernaesthetics.com/news/coolsculpting-elite-announces-first-ever-coolmonth/2473386/April 2023 marks the first-ever CoolMonth, according to Allergan Aesthetics, an AbbVie company and the parent company of CoolSculpting Elite. Why April? A survey revealed 85% of people have a season in which they begin to think more about getting rid of stubborn body fat, and for 4
- EON Robotic Body Contouring Device Gains Additional FDA Clearance for Back and Thighshttps://modernaesthetics.com/news/eon-robotic-body-contouring-device-gains-additional-fda-clearance-for-back-and-thighs/2473380/EON Smarter Body Contouring has received FDA clearance for the back and thighs—the third FDA clearance for EON. The device was previously FDA-cleared for clinical providers to treat patients' full abdomen and flanks. Parent company Dominion Aesthetic Technologies describe
- ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals in Korea and Hyaluronic Acid (HA) Dermal Fillers in Brazilhttps://modernaesthetics.com/news/exocobio-obtains-gmp-licenses-for-exosome-biopharmaceuticals-in-korea-and-hyaluronic-acid-ha-dermal-fillers-in-brazil/2473370/ExoCoBio announced that it has obtained the "Certificate of Advanced Biopharmaceutical Manufacturing" from the Ministry of Food and Drug Safety in Korea, and the "HA Filler GMP Certification" from the Brazilian Food and Drug Health Monitoring Agency (ANVISA). Accordi
- Galderma Celebrates Self-Expression at Miami Art Week 2022https://modernaesthetics.com/news/galderma-celebrates-self-expression-at-miami-art-week-2022/2473335/Galderma is the exclusive aesthetic injectables sponsor of the 21st annual SCOPE Miami Beach 2022 art show. Galderma will be highlighting its aesthetics portfolio – Restylane, Dysport (abobotulinumtoxinA) and Sculptra – and hosting a variety of